Cholinesterase (Serum) Outsource AKU Test at Chughtai Lab

Cholinesterase (Serum) outsource AKU at Chughtai Lab

The Cholinesterase (Serum) outsource AKU test is a highly specialized diagnostic laboratory investigation designed to measure the activity of the cholinesterase enzyme in the blood. Specifically, this assay evaluates pseudocholinesterase, also known as butyrylcholinesterase (BChE), which is synthesized by the liver and secreted into the blood plasma. This enzyme is clinically distinct from acetylcholinesterase (AChE), which is found primarily in red blood cells, nervous tissue, and neuromuscular junctions. Measuring serum cholinesterase activity is of paramount clinical importance in toxicology, anesthesiology, occupational health, and hepatology. It serves as a vital diagnostic tool for evaluating pesticide poisoning, assessing pre-operative risk for prolonged neuromuscular blockade, and monitoring hepatic synthetic function.

Chughtai Lab, a premier diagnostic network in Pakistan, facilitates this specialized test through a strategic outsourcing arrangement with the Aga Khan University (AKU) Clinical Laboratory in Karachi. The AKU Clinical Laboratory is an internationally accredited, College of American Pathologists (CAP) certified facility, ensuring that your blood sample is analyzed using state-of-the-art kinetic enzymatic spectrophotometry. By collecting the sample at any Chughtai Lab branch across Pakistan and utilizing a highly controlled cold chain transport system, patients receive reference-level diagnostic accuracy combined with the local convenience and digital reporting efficiency of Chughtai Lab.

The primary diagnostic value of the Cholinesterase (Serum) outsource AKU test lies in its sensitivity to external inhibitors and genetic variations. Organophosphate and carbamate chemical compounds, commonly found in agricultural pesticides and insecticides, act as potent inhibitors of cholinesterase enzymes. Exposure to these toxins leads to a rapid and significant drop in serum cholinesterase levels. Additionally, certain individuals inherit genetic variants of the BCHE gene, resulting in a hereditary deficiency of functional pseudocholinesterase. When these patients are administered common muscle relaxants, such as succinylcholine or mivacurium, during general anesthesia, they are unable to metabolize the drug efficiently, leading to prolonged, potentially life-threatening muscle paralysis and respiratory apnea. This test provides the critical data physicians need to prevent these complications, manage acute toxic exposures, and monitor occupational safety.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the clinical accuracy of the Cholinesterase (Serum) outsource AKU test. Patients are advised to adhere to the following guidelines prior to sample collection:

• Medication Disclosure: Inform your prescribing physician and the phlebotomist of all medications, supplements, and over-the-counter drugs you are currently taking. Specific drugs, including oral contraceptives, neuromuscular blockers, neostigmine, pyridostigmine, metoclopramide, and certain cardiovascular medications, can alter serum cholinesterase activity.
• Fasting Requirements: Routine fasting is generally not required for this test. However, if other concurrent blood tests are ordered alongside it, a fasting period of 8 to 12 hours may be necessary. Always follow the specific instructions provided by your physician.
• History of Chemical Exposure: If the test is being performed due to suspected pesticide exposure or as part of occupational monitoring, document the date, time, and type of chemical exposure, and share this information with the healthcare team.
• Anesthesia History: If you or any close family members have ever experienced prolonged muscle weakness, breathing difficulties, or delayed recovery after receiving general anesthesia, ensure this clinical history is noted on your requisition form.

During the Procedure

The collection of a blood sample for the Cholinesterase (Serum) outsource AKU test is a standard, minimally invasive phlebotomy procedure performed by trained healthcare professionals at Chughtai Lab. The process involves the following steps:

• Patient Identification and Verification: The phlebotomist will verify your identity using your registration details and confirm the specific test requirements, including any relevant clinical history or medication use.
• Site Selection and Preparation: You will be seated comfortably. The phlebotomist will inspect your arm to locate a suitable vein, typically the median cubital vein in the antecubital fossa. The selected site is thoroughly cleansed with an antiseptic solution (70% isopropyl alcohol) and allowed to air dry to prevent sample contamination.
• Venipuncture: A sterile, single-use needle is gently inserted into the vein. A vacuum collection tube, typically a serum separator tube (SST) or a plain red-top tube, is attached to draw the required volume of blood. You may feel a brief, mild pinch as the needle enters the skin.
• Sample Processing: Once the blood draw is complete, the needle is withdrawn, and gentle pressure is applied to the puncture site with a sterile cotton swab to stop any bleeding. A small adhesive bandage is applied. The collected blood tube is labeled immediately in your presence with unique barcoded identifiers.
• Cold Chain Transport: Because this is an outsourced investigation, the serum is separated from the cellular components via centrifugation under controlled temperatures. The serum sample is then packaged in a specialized, temperature-monitored transport container to maintain the cold chain during transit to the AKU reference laboratory in Karachi, preserving enzyme stability and ensuring accurate results.

When is a Cholinesterase (Serum) outsource AKU Performed?

Diagnosis of Organophosphate and Carbamate Poisoning

Physicians request this test immediately when a patient presents with signs and symptoms of acute or chronic exposure to organophosphate or carbamate pesticides. These chemicals are widely used in agriculture and can be absorbed through inhalation, dermal contact, or ingestion. Inhibiton of cholinesterase leads to an accumulation of acetylcholine, causing cholinergic crisis. Symptoms include pinpoint pupils (miosis), excessive salivation, lacrimation, bronchospasm, muscle twitching, gastrointestinal cramping, diarrhea, and in severe cases, respiratory failure. The test confirms the diagnosis and helps assess the severity of the toxicity.

Pre-Anesthetic Screening for Pseudocholinesterase Deficiency

This investigation is performed prior to elective surgeries requiring general anesthesia, particularly for patients with a personal or family history of post-operative respiratory complications. If a patient has an inherited deficiency or an atypical variant of the pseudocholinesterase enzyme, they cannot rapidly metabolize succinylcholine or mivacurium. This leads to prolonged neuromuscular blockade, meaning the patient remains paralyzed and unable to breathe on their own for hours after the surgery has concluded. Pre-operative testing allows anesthesiologists to select alternative, safer muscle relaxants.

Occupational Health Monitoring for Agricultural and Chemical Workers

For individuals working in pesticide manufacturing plants, agricultural spraying, pest control, or chemical research facilities, this test is performed as part of a routine occupational health surveillance program. A baseline serum cholinesterase level is established before the individual begins working with these hazardous chemicals. Periodic testing is then conducted to monitor for subclinical exposure. A significant decrease in enzyme activity compared to the baseline indicates chemical absorption, prompting immediate safety interventions and temporary removal of the worker from the high-risk environment.

Assessment of Severe Liver Disease and Synthetic Function

Because pseudocholinesterase is synthesized exclusively by hepatocytes in the liver, its serum activity serves as an indicator of hepatic synthetic capacity. Gastroenterologists and hepatologists may order this test to evaluate the severity of advanced liver diseases, such as decompensated cirrhosis, acute liver failure, toxic hepatitis, or hepatic malignancies. A progressive decline in serum cholinesterase levels correlates with a reduction in functional liver mass and can assist in prognostic assessments and liver transplant evaluations.

Evaluation of Unexplained Prolonged Muscle Weakness

This test is indicated in clinical scenarios where a patient experiences unexplained, persistent muscle weakness, fatigue, or localized paralysis, especially following exposure to household chemicals, therapeutic drugs, or surgical procedures. It helps clinicians differentiate between primary neuromuscular disorders, autoimmune conditions like myasthenia gravis, and acquired or inherited enzyme deficiencies that impair normal neuromuscular transmission.

What Does a Cholinesterase (Serum) outsource AKU Detect?

The Cholinesterase (Serum) outsource AKU test is highly sensitive and can detect a wide range of physiological, pathological, genetic, and toxicological conditions. Specifically, the assay is capable of detecting:

• Acute organophosphate pesticide toxicity, characterized by a rapid and severe reduction in enzyme activity.
• Chronic, low-grade exposure to carbamate insecticides in agricultural workers.
• Homozygous atypical pseudocholinesterase deficiency, a genetic condition causing extreme sensitivity to succinylcholine.
• Heterozygous atypical pseudocholinesterase deficiency, resulting in moderate sensitivity and mildly prolonged drug metabolism.
• Impaired hepatic synthetic function due to advanced liver cirrhosis.
• Acute toxic or viral hepatitis, leading to a temporary decrease in enzyme production.
• Severe protein-calorie malnutrition, which reduces the liver’s capacity to synthesize essential proteins and enzymes.
• Advanced metastatic malignancies, which are frequently associated with depressed serum cholinesterase levels.
• Physiological decreases in enzyme activity during the third trimester of pregnancy.
• Drug-induced enzyme inhibition caused by therapeutic agents such as neostigmine, pyridostigmine, or physostigmine.
• The impact of oral contraceptive use, which can cause a mild, clinically benign reduction in serum cholinesterase.
• Subclinical chemical absorption in pesticide handlers before clinical symptoms of toxicity manifest.
• Recovery of hepatic synthetic function following successful treatment of liver disease or nutritional rehabilitation.
• Gradual restoration of enzyme levels following successful treatment of organophosphate poisoning with pralidoxime (2-PAM).
• Systemic inflammatory response syndrome (SIRS) or severe infections, which can downregulate hepatic protein synthesis.
• Congestive heart failure leading to hepatic congestion and subsequent reduction in enzyme synthesis.
• The presence of rare genetic variants of the BCHE gene, such as the fluoride-resistant or silent alleles, when combined with dibucaine inhibition studies.
• Severe thermal burns, which cause massive metabolic stress and a temporary drop in serum proteins.
• Renal disease or nephrotic syndrome, which occasionally presents with altered or elevated serum cholinesterase levels.
• Hyperthyroidism, which in rare clinical instances can cause an elevation in serum cholinesterase activity.

Turnaround Time and Report Access at Chughtai Lab

Because the Cholinesterase (Serum) outsource AKU test requires specialized analytical methodologies, the blood sample is collected at Chughtai Lab and securely transported to the Aga Khan University (AKU) Clinical Laboratory in Karachi. Due to the specialized nature of this outsourced assay and the logistics of maintaining a strict cold chain during transit, the turnaround time (TAT) for the final verified report is typically 3 to 5 working days.

Chughtai Lab is committed to providing seamless and convenient access to diagnostic reports. Once the analysis is completed and verified by the consulting pathologists at the reference laboratory, the results are immediately integrated into the Chughtai Lab digital database. Patients and their referring physicians are notified via SMS. Reports can be accessed, viewed, and downloaded through multiple digital channels, including the Chughtai Lab official website portal, the user-friendly Chughtai Lab mobile application, or directly via WhatsApp. Physical copies of the report can also be collected from any convenient Chughtai Lab collection center across the country.

Cholinesterase (Serum) outsource AKU Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Serum Cholinesterase Activity	Within established reference range (typically 5,300 to 12,900 U/L, varying slightly by age and sex).	Decreased: Organophosphate/carbamate poisoning, genetic deficiency, liver disease, malnutrition. Increased: Nephrotic syndrome, hyperthyroidism, obesity (rare).
Pesticide Exposure Status	No significant inhibition; enzyme activity matches baseline or population norms.	Significant reduction (often >50% drop from baseline in acute poisoning cases).
Hepatic Synthetic Capacity	Normal enzyme levels indicating healthy, functioning hepatocytes.	Markedly reduced levels in decompensated cirrhosis, liver failure, or severe hepatitis.
Genetic Variant Influence	Normal enzyme structure and activity; rapid metabolism of neuromuscular blockers.	Extremely low activity (homozygous atypical variant) or moderately low activity (heterozygous variant).
Nutritional Marker Status	Adequate protein synthesis reflecting balanced nutritional intake.	Depressed enzyme levels secondary to severe protein-energy malnutrition or cachexia.
Drug-Induced Inhibition	No therapeutic interference with enzyme activity.	Reduced activity due to active treatment with anticholinesterase drugs (e.g., pyridostigmine).
Pregnancy / Hormonal Status	Normal or slightly lower physiological levels within expected limits for gestational age.	Clinically significant drops in late pregnancy or during high-dose oral contraceptive therapy.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Cholinesterase (Serum) outsource AKU?

• Reference Lab Partnership: Seamless integration with the Aga Khan University (AKU) Clinical Laboratory ensures access to CAP-accredited, internationally recognized testing methodologies.
• Uncompromised Cold Chain: Strict temperature-controlled transport protocols preserve sample integrity from the moment of collection until analysis.
• Vast Collection Network: Convenient sample collection is available at hundreds of Chughtai Lab branches and collection centers across Pakistan.
• Expert Phlebotomy Services: Highly trained and compassionate phlebotomists ensure a safe, hygienic, and virtually painless blood draw experience.
• Advanced Digital Access: Quick and secure online report retrieval through the Chughtai Lab mobile app, official website, and WhatsApp.
• Comprehensive Patient Care: Dedicated 24/7 customer support helpline to assist with test bookings, preparation inquiries, and report status.
• Home Sample Collection: Convenient home health services allow patients to have their blood drawn in the comfort of their own homes.
• Commitment to Accuracy: Stringent internal and external quality control measures guarantee highly reliable and clinically precise diagnostic results.